Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Charles A. Strongo M.B.A., BA, MBA

Market Cap

223.19 Thousand USD

Sector

Healthcare

Website

https://gwhpcorp.com

Description

Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States.

Read More

Overview

Value

1

Growth

2

Health

23

Management

70

Analyst Opinion

60

Total

31

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth

Market Peers

GWHP

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-697.28%

Revenue Growth (5 Year Average)

-12.28%

Ratings Consensus

Neutral

Share Buybacks

-151.64%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 1.70 undefined USD)
  • Free-cashflow-yeild of -881.86% is worse than the market average (4.7%)
  • Margin-of-safety of -697.28% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-881.86%

PE/Earnings Growth

N/A

Price/Book

-0.14x

Growth

Growth Score

2

  • 5 Year Average Revenue growth of -12.28% is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of -25.64% is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -9.69% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

-12.28%

Earnings Growth

-25.64%

Cashflow Growth

-9.69%

Health

Health Score

23

  • Has a low level of debt
  • Cashflow is negative
  • 0
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

3.00

Debt/Equity

N/Ax

Current Assets/Liabilities

0.01x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

34.15x

Management

Management Score

70

  • Has issued new shares to finance growth when share price is high
  • Return-on-equity of 459234.98% is higher than the market average (15%)
  • Return-on-capital-employed of -257.82% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity

Average Buybacks/Dilution

-151.64%

Recent Buybacks/Dilution

39.81%

5 Year Price Volitility

135.10%

Return On Assets

-27157710.25%

Return On Capital Employed

-257.82%

Return On Equity

459234.98%

Return On Free Cashflow

1115206.29%

Return On Investments

N/A

Analysts

Analyst Opinion

60

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Global WholeHealth Partners Corporation

Currency

USD

Beta

2.128705

Vol Avg

190739

Ceo

Mr. Charles A. Strongo M.B.A., BA, MBA

Cik

0001598308

Cusip

37959N102

Exchange

Other OTC

Full Time Employees

Industry

Diagnostics & Research

Sector

Healthcare

Ipo Date

2021-01-08

Address

227 Avenida Oliva

City

San Clemente

State

CA

Country

US

Zip

92660

Phone

702 318 7554

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies